课题基金 / 基金详情

Establishment of mouse-directed HCV infection models

Establishment of mouse-directed HCV infection models
小鼠HCV感染模型的建立
批准号:
22659145
负责人:
SAKAMOTO Naoya
金额:
$2.04万
依托单位国家:
日本
项目类别:
Grant-in-Aid for Challenging Exploratory Research
财政年份:
2010
资助国家:
日本
项目状态:
已结题
起止时间:
2010 至 2011

项目摘要

项目成果

SAKAMOTO Naoya的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
In our present study, we constructed two fluorescence protein-tagged recombinant JFH1 virus clones, JFH1-EYFP and JFH1-AsRed, as well as two corresponding clones with adaptive mutations, JFH1-EYFP mutant and JFH1-AsRed mutant, that and were as effective as JFH1 in producing infectious virus particles, and investigated their viral infection life cycles. After infection of the fluorescence-tagged mutant viruses, infected cells increased exponentially. In cells, EYFP or AsRed and NS5A were expressed as a fusion protein and co-localized in core proteins. The rate of the cell. cell spread was dependent on the cell densities with a maximum of 102. 5/day. Treatment of cells with interferon or a protease inhibitor suppressed expansion of virus-positive cells. Taken together, these results indicate that fluorescence-tagged HCV is a useful tool to study virus infection life cycles and to assist in the search for novel antiviral compounds.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Serum interleukin-6 levels correlate with resistance to treatment of chronic hepatitis C infection with pegylated-interferon-alpha2b plus ribavirin
血清白细胞介素 6 水平与聚乙二醇干扰素 α2b 加利巴韦林治疗慢性丙型肝炎感染的耐药性相关
DOI: --
发表时间: 2011
期刊: Antivir Ther
影响因子: 1.2
作者: [Ueyama M, Nakagawa M, Sakamoto N, et al.]
通讯作者: et al.
Mutations in the interferon sensitivity determining region of HCV, age and total ribavirin dose is an independent predictor of relapse among early virological responders to peg-interferon plus ribavirin therapy
HCV 干扰素敏感性决定区、年龄和利巴韦林总剂量的突变是对聚乙二醇干扰素联合利巴韦林治疗的早期病毒学应答者中复发的独立预测因素
DOI: --
发表时间: 2011
期刊:
影响因子: --
作者: [Kurosaki M, Sakamoto N, Nakagawa M, et al.]
通讯作者: et al.
Inhibition of HCV replication by a specific inhibitor of serin-arginine-rich protein kinase
富含丝氨酸-精氨酸的蛋白激酶的特异性抑制剂抑制 HCV 复制
DOI: --
发表时间: 2010
期刊: Antimicrob Agent Chemother
影响因子: --
作者: [Karakama Y, Sakamoto N, Itsui Y, Nakagawa M, Tasaka-Fujita M, Nishimura-Sakurai Y, Kakinuma S, Oooka S, Azuma S, Tsuchiya K, Onogi H, Hagiwara M, Watanabe M.]
通讯作者: Watanabe M.
A new method for induced fit docking (GENIUS) and its application to virtual screening of novel HCV NS3-4A protease inhibitors
诱导拟合对接新方法(GENIUS)及其在新型HCV NS3-4A蛋白酶抑制剂虚拟筛选中的应用
DOI: 10.1016/j.bmc.2011.09.023
发表时间: 2011
期刊: Bioorganic & Medicinal Chemistry
影响因子: 3.5
作者: [Takaya D, Sakamoto N, et al.]
通讯作者: et al.
57
    Origin of -OH in meteoritic hydrous minerals
    • 批准号:
      25800299
    • 项目类别:
      Grant-in-Aid for Young Scientists (B)
    • 资助金额:
      $2.58万
    • 财政年份:
      2013
    • 负责人:
      SAKAMOTO Naoya
    • 依托单位:
    High throughput screening of chemical library for antiviral compounds for hepatitis viruses
    • 批准号:
      24390185
    • 项目类别:
      Grant-in-Aid for Scientific Research (B)
    • 资助金额:
      $11.48万
    • 财政年份:
      2012
    • 负责人:
      SAKAMOTO Naoya
    • 依托单位:
    Mineral isochron of fine grained CAI using stigmatic isotope imaging method
    • 批准号:
      24654179
    • 项目类别:
      Grant-in-Aid for Challenging Exploratory Research
    • 资助金额:
      $1.5万
    • 财政年份:
      2012
    • 负责人:
      SAKAMOTO Naoya
    • 依托单位:
    Tumor-stromal cell interaction and epithelial-mesenchymal transition by secreted-microRNA
    • 批准号:
      23790403
    • 项目类别:
      Grant-in-Aid for Young Scientists (B)
    • 资助金额:
      $2.75万
    • 财政年份:
      2011
    • 负责人:
      SAKAMOTO Naoya
    • 依托单位:
    国内基金
    海外基金
    γδT细胞调控CD81高表达单核细胞亚群功能参与脓毒症的作用机制及预后价值研究
    • 批准号:
      --
    • 项目类别:
      青年科学基金项目
    • 资助金额:
      --
    • 批准年份:
      2024
    • 负责人:
      李俐漫
    • 依托单位:
    CD81共刺激信号对CAR-T相关细胞因子风暴的影响及其机制研究
    • 批准号:
      82300252
    • 项目类别:
      青年科学基金项目
    • 资助金额:
      30万元
    • 批准年份:
      2023
    • 负责人:
      何柏林
    • 依托单位:
    α-1,6-半乳聚糖靶向CD81调节血糖的构效关系及作用机制
    • 批准号:
      32371341
    • 项目类别:
      面上项目
    • 资助金额:
      50万元
    • 批准年份:
      2023
    • 负责人:
      范玉莹
    • 依托单位:
    CD81/SDC1介导的免疫逃逸在胶质瘤辐射抵抗中的作用及其机制研究
    • 批准号:
      --
    • 项目类别:
      面上项目
    • 资助金额:
      58万元
    • 批准年份:
      2021
    • 负责人:
      邵春林
    • 依托单位: